Rural Health
News by Topic: Legislation and regulations
Mar 14, 2024 - Announces proposed bipartisan legislation aiming to reduce burdens on rural Medicare patients seeking healthcare in an Accountable Care Organization (ACO). The bill expands the ability of Medicare beneficiaries to be assigned to an ACO by allowing assignments based on primary care visits performed by nurse practitioners, physician assistants, or clinical nurse specialists.
Source: Office of Representative Suzan DelBene
Mar 14, 2024 - Following an annual assessment of telecommunications capability, the Federal Communications Commission has raised the benchmark for broadband download and upload speeds. Notes that broadband deployment in rural and tribal areas is not happening in a reasonable timeframe.
Source: Federal Communications Commission
CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
Federal Register
Mar 13, 2024 - The Centers for Medicare & Medicaid Services (CMS) is
seeking comments on the following information collections:
1) Ambulatory Surgical Center Conditions for Coverage; 2)
Implementation of the Medicare Prescription Drug Plan (PDP)
and Medicare Advantage (MA) Plan Disenrollment Reasons
Survey; and 3) Transitional Pass through payments related
to Drugs, Biologicals, and Radiopharmaceuticals to
determine eligibility under the Outpatient Prospective
Payment System. Comments are due by May 13, 2024.
Source: Federal Register
Mar 12, 2024 - Offers overview of a meeting between the U.S. Department of Health and Human Services, other Administration officials, and healthcare stakeholders related to the Change Healthcare cyberattack. Highlights key actions taken by the Administration to address impacts.
Source: U.S. Department of Health and Human Services
Mar 11, 2024 - Offers overview of priorities in the proposed Fiscal Year 2025 Budget for the Health Resources & Services Administration including youth mental health, maternity care deserts, access to primary care, opioid treatment and recovery, the healthcare workforce, and organ donation. Discusses rural specific needs throughout.
Source: Health Resources & Services Administration
FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability
Federal Register
Mar 11, 2024 - Notice from the Food and Drug Administration (FDA) announcing the revocation of one Emergency Use Authorization (EUA) issued to Eli Lilly and Co. (Lilly) for bamlanivimab and etesevimab administered together. The revocation is effective December 14, 2023.
Source: Federal Register